24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Aya Jakobovits
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:28
Full list of Israeli startup M&As in 2025
17:24
Fintech unicorn Tipalti acquires Statement to expand real-time cash flow management
15:02
Full list of Israeli high-tech funding rounds in 2025
15:00
Coralogix raises $115 million Series E at over $1 billion valuation
More stories
Buzz
Most popular
Daily
Weekly
1
“We made another investment the morning after the war with Iran began”
2
Intel to begin foundry layoffs in July, but uncertainty hangs over Israel amid wartime reality
3
Cyberattacks against Israel surge 700% in two days, says Radware
4
Google’s $32 billion acquisition of Wiz draws antitrust attention
5
Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal
More news
Aya Jakobovits
2 stories about Aya Jakobovits
Covid-19 was one of the biomed industry’s finest hours, says Israeli Silicon Valley veteran
15.12.20
|
Ron Friedman
Aya Jakobovits, a trailblazer in the biomed sector who is participating in J-Ventures’ annual investor’s conference, speaks of how the coronavirus vaccines showcased the depth of new technology
Allogenic Immunotherapy Company Adicet Bio Raises $80 Million
02.10.19
|
Meir Orbach
Founded by Israeli chemist Aya Jakobovits, Adicet develops universal immune cell therapies based on gamma delta T cells to treat different forms of cancer